![]() |
CAS No. : | 1672668-24-4 |
Cat. No. : | A1216748 | |
Formula : | C17H12F3NO4S | |
Purity : | 98% | |
M.W : | 383.34 g/mol | |
Synonyms : | ||
MDL No. : | MFCD32197212 | |
Storage : | Inert atmosphere, room temperature | |
InChI Key : | N/A | |
Pubchem ID : | 117947097 | |
Linear Structure Formula : | - | |
Boiling Point : | - |
Safety of [ 1672668-24-4 ] | |||
---|---|---|---|
Signal Word : | Warning | Class : | N/A |
Precautionary Statements : | P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501 | UN# : | N/A |
Hazard Statements : | H302-H315-H319-H335 | Packing Group : | N/A |
GHS Pictogram : |
![]() |
Biological Activity of [ 1672668-24-4 ] | |
---|---|
Description : |
Belzutifan (PT2977), an orally bioavailable and selective inhibitor of HIF-2α, has an IC50 value of 9 nM. As a second-generation HIF-2α inhibitor, it offers enhanced potency and an optimized pharmacokinetic profile. Belzutifan holds promise as a treatment option for clear cell renal cell carcinoma (ccRCC)[1].
Show More |